Publicaciones y presentaciones
Descubra los principales aspectos destacados de nuestra industria en nuestras publicaciones más recientes.
Acceso Rápido
Presentaciones
Publicaciones
Key Economic & Value Considerations in the US
Market for PPTs
Market for PPTs
Key Economic & Value Considerations for PDMPs
in Europe
in Europe
Plasma donation: New thinking to serve Europe’s patients -- Practices & approaches for countries
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Nov 3, 2020
Plasma Saves Lives: Addressing the COVID-19 Pandemic
The Pathogen Safety Steering Committee (PSSC) issued a statement confirming that the coronavirus is not a threat to the safety of plasma-deriver therapies. The statement was made available for download in multiple languages including Czech, French, German, Italian, Portugues, and Spanish.
All
Presentation
https://prezi.com/view/NWUEmOxAg50YI92g7rxx/
Nov 3, 2020
Plasma Saves Lives: Addressing the COVID-19 Pandemic
The Pathogen Safety Steering Committee (PSSC) issued a statement confirming that the coronavirus is not a threat to the safety of plasma-deriver therapies. The statement was made available for download in multiple languages including Czech, French, German, Italian, Portugues, and Spanish.
All
Presentation
https://prezi.com/view/NWUEmOxAg50YI92g7rxx/
Nov 1, 2020
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years experience of the plasma protein manufacturers
Nanofiltration entails the filtering of protein solutions through membranes with pores of nanometric sizes that have the capability to effectively retain a wide range of viruses.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/32815181/
Nov 1, 2020
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years experience of the plasma protein manufacturers
Nanofiltration entails the filtering of protein solutions through membranes with pores of nanometric sizes that have the capability to effectively retain a wide range of viruses.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/32815181/
Oct 14, 2020
Ensuring Appropriate Patient Access to Plasma Derived Medicinal Products – Event Report
On October 14 2020 took place an online roundtable event “Ensuring Appropriate Patient Access to Plasma-Derived Medicinal Products [PDMPs] — Before, During and After COVID-19, Challenges and Solutions”, organized and co-hosted by Member of the European Parliament (MEP) Manuel Pizarro, (S&D, Portugal) and MEP Helmut Geuking (ECR, Germany), and moderated by Brian Maguire, an independent journalist and producer at EBX Media.
All
Presentation
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6454e96e3fe5c74f92dc4df6_Online%20Rountable%20on%20Access%20to%20PDMPs%2014Oct2020_Report_.pdf
Oct 14, 2020
Ensuring Appropriate Patient Access to Plasma Derived Medicinal Products – Event Report
On October 14 2020 took place an online roundtable event “Ensuring Appropriate Patient Access to Plasma-Derived Medicinal Products [PDMPs] — Before, During and After COVID-19, Challenges and Solutions”, organized and co-hosted by Member of the European Parliament (MEP) Manuel Pizarro, (S&D, Portugal) and MEP Helmut Geuking (ECR, Germany), and moderated by Brian Maguire, an independent journalist and producer at EBX Media.
All
Presentation
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6454e96e3fe5c74f92dc4df6_Online%20Rountable%20on%20Access%20to%20PDMPs%2014Oct2020_Report_.pdf
Jun 3, 2020
Industry call for COVID-19 convalescent plasma collections
The treatment of COVID-19 patients, especially in severe conditions, presents a challenge to medical professionals. Plasma from recovered COVID-19 patients is a potential and promising therapeutic option, and efforts are underway at different levels to encourage convalescent plasma donations [1, 2].
All
Publication
https://onlinelibrary.wiley.com/doi/full/10.1111/voxs.12571
Jun 3, 2020
Industry call for COVID-19 convalescent plasma collections
The treatment of COVID-19 patients, especially in severe conditions, presents a challenge to medical professionals. Plasma from recovered COVID-19 patients is a potential and promising therapeutic option, and efforts are underway at different levels to encourage convalescent plasma donations [1, 2].
All
Publication
https://onlinelibrary.wiley.com/doi/full/10.1111/voxs.12571
No results found